Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $122.03 USD
Change Today -4.84 / -3.81%
Volume 1.3M
As of 5:20 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by VERTEX PHARMACEUTICALS INC (VRTX) in the last 6 months

Announced 06/4/15
940.00M for Parion Sciences, Inc., P-1037 and P-1055 Global Development And Commercialization Rights
Merger/Acquisition

Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) entered into an agreement to acquire P-1037 and P-1055 global development and commercialization rights from Parion Sciences, Inc. for $940 million on June 4, 2015. An upfront payment of $80 million from Vertex and up to (i) $490 million in development and regulatory milestone payments for development of ENaC inhibitors in CF, including $360 million related to global filing and approval milestones, (ii) $370 million ...
Read More


VRTX's price was unchanged after the transaction was announced on 06/4/15.
Investor / Buyer
Vertex Pharmaceuticals Incorporated
Creditor / Lender
Parion Sciences, Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $122.03 USD -4.84

VRTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $62.92 USD -2.83
BioMarin Pharmaceutical Inc $132.31 USD -2.53
Incyte Corp $100.82 USD -3.23
Jazz Pharmaceuticals PLC $170.60 USD -3.52
Sigma-Aldrich Corp $139.33 USD -0.18
View Industry Companies
 

Industry Analysis

VRTX

Industry Average

Valuation VRTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 50.6x
Price/Book 31.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 48.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.